Disc Medicine, Inc.
IRON
$42.17
$1.172.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -43.08% | -61.45% | -37.63% | -34.88% | -63.22% |
| Total Depreciation and Amortization | 56.00% | 72.00% | 87.88% | 5.21% | 12.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.94% | 243.82% | 20.39% | 181.76% | 146.51% |
| Change in Net Operating Assets | 209.41% | 307.85% | 171.52% | 99.85% | -238.96% |
| Cash from Operations | -27.86% | -28.80% | -9.94% | -11.84% | -73.87% |
| Capital Expenditure | -467.42% | 39.80% | -55.56% | -58.75% | 41.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -328,362.92% | -296,745.92% | -305,266.67% | -58.75% | 41.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -5.49% | -42.82% | -42.71% | -15.72% | 33.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.71% | -100.00% | -100.16% | -64.33% | 1,852.75% |
| Cash from Financing | -8.80% | -48.15% | -48.08% | -21.33% | 60.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.28% | -156.44% | -130.99% | -34.47% | 55.60% |